CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer

被引：61

作者：

Bastian, Patrick J. ^{[1
,2
,3
]}

Palapattu, Ganesh S. ^{[2
,3
]}

Yegnasubramanian, Srinivasan ^{[2
,3
,6
]}

Rogers, Craig G. ^{[2
,3
]}

Lin, Xiaohui ^{[4
]}

Mangold, Leslie A. ^{[2
,3
]}

Trock, Bruce ^{[2
,3
]}

Eisenberger, Mario A. ^{[2
,3
,4
,7
]}

Partin, Alan W. ^{[2
,3
]}

Nelson, William G. ^{[2
,3
,4
,5
,6
,7
]}

机构：

[1] Univ Munich, Univ Klinikum Grosshadern, Urol Klin & Poliklin, D-81377 Munich, Germany

[2] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA

[3] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD USA

[4] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD USA

[5] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD USA

[6] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD USA

[7] Johns Hopkins Univ, Sch Med, Sydney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

来源：

JOURNAL OF UROLOGY | 2008年 / 179卷 / 02期

关键词：

prostate; prostatic neoplasms; tumor markers; biological; glutathione S-transferase pi; neoplasm recurrence; local;

D O I：

10.1016/j.juro.2007.09.038

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose: We have noted that hypermethylation at GSTP1 in the preoperative serum of men with localized prostate cancer predicts early prostate specific antigen failure following surgical treatment. In this study we investigated the hypermethylation profile of several genes in the serum of men with localized and hormone refractory prostate cancer. Materials and Methods: We assayed the serum of 192 men with clinically localized prostate cancer and 18 with hormone refractory metastatic disease. A total of 35 serum samples from patients with negative prostate biopsy served as a negative control. CpG Island hypermethylation status of certain genes was assessed, including MDR1, EDNRB, CD44, NEP, PTGS2, RASSF1A, RAR-beta and ESR1. The results of hypermethylation at GSTP1 were included from a previous study. Results: CpG island hypermethylation at MDR1 was positive in 38.2% of cases without PSA recurrence and in 16.1% of those with biochemical recurrence after radical prostatectomy. DNA hypermethylation at the remaining 7 gene loci was not detected in the serum of patients with localized prostate cancer. In serum from metastatic prostate cancer cases CpG island hypermethylation was detected at MDR1 in 15 (83.3%), EDNRB in 9 (50%), RAR-beta in 7 (38.9%), GTSP1 in 5 (27.8%) and NEP or RASSF1A in 3 (16.7%). CpG island hypermethylation at CD44, PTGS2 or ESR was not detected in any samples. All histologically normal cases were negative for CpG island hypermethylation. Conclusions: DNA hypermethylation at MDR1 was detected in cases of localized prostate cancer. CpG island hypermethylation at several gene loci was detected in men with advanced disease. No single gene was consistently observed to be hypermethylated in men with hormone refractory disease. These results suggest that the CpG island hypermethylation status of a defined panel of genes may be a useful biomarker in men with hormone refractory prostate cancer.

引用

页码：529 / 534

页数：6

共 20 条

[1] Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy [J].

Bastian, Patrick J. ;

Ellinger, Joerg ;

Heukamp, Lukas C. ;

Kahl, Philip ;

Mueller, Stefan C. ;

von Ruecker, Alexander .

EUROPEAN UROLOGY, 2007, 51 (03) :665-674

[2] Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10 [J].

Bastian, Patrick J. ;

Gonzalgo, Mark L. ;

Aronson, William J. ;

Terris, Martha K. ;

Kane, Christopher J. ;

Amling, Christopher L. ;

Presti, Joseph C., Jr. ;

Mangold, Leslie A. ;

Humphreys, Elizabeth ;

Epstein, Jonathan I. ;

Partin, Alan W. ;

Freedland, Stephen J. .

CANCER, 2006, 107 (06) :1265-1272

[3] Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci [J].

Bastian, PJ ;

Ellinger, J ;

Wellmann, A ;

Wernert, N ;

Heukamp, LC ;

Müller, SC ;

von Ruecker, A .

CLINICAL CANCER RESEARCH, 2005, 11 (11) :4097-4106

[4] Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy [J].

Bastian, PJ ;

Palapattu, GS ;

Lin, XH ;

Yegnasubramanian, S ;

Mangold, LA ;

Trock, B ;

Eisenberger, MA ;

Partin, AW ;

Nelson, WG .

CLINICAL CANCER RESEARCH, 2005, 11 (11) :4037-4043

[5] Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma MA biomarker for detecting prostate carcinoma [J].

Chuang, Cheng-Keng ;

Chu, Da-Chang ;

Tzou, Ron-Dar ;

Liou, Shu I. ;

Chia, Ju-Hsin ;

Sun, Chien-Feng .

CANCER DETECTION AND PREVENTION, 2007, 31 (01) :59-63

[6]

Goessl C, 2000, CANCER RES, V60, P5941

[7]

Jerónimo C, 2002, UROLOGY, V60, P1131

[8] Quantitative RARβ2 hypermethylation:: A promising prostate cancer marker [J].

Jerónimo, C ;

Henrique, R ;

Hoque, MO ;

Ribeiro, FR ;

Oliveira, J ;

Fonseca, D ;

Teixeira, MR ;

Lopes, C ;

Sidransky, D .

CLINICAL CANCER RESEARCH, 2004, 10 (12) :4010-4014

[9] LUMA (LUminometric Methylation Assay) -: A high throughput method to the analysis of genomic DNA methylation [J].

Karimi, Mohsen ;

Johansson, Sofia ;

Stach, Dirk ;

Corcoran, Martin ;

Grander, Dan ;

Schalling, Martin ;

Bakalkin, Georgy ;

Lyko, Frank ;

Larsson, Catharina ;

Ekstrom, Tomas J. .

EXPERIMENTAL CELL RESEARCH, 2006, 312 (11) :1989-1995

[10] Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients [J].

Koyanagi, Kazuo ;

Mori, Takuji ;

O'Day, Steven J. ;

Martinez, Steve R. ;

Wang, He-Jing ;

Hoon, Dave S. B. .

CANCER RESEARCH, 2006, 66 (12) :6111-6117

← 1 2 →